Company Overview and News
In a retail environment characterized by several pressures and significant headwinds for both the small and big retailers, Ross Stores (ROST) has been an important exception. While department stores and the rest of the retail sector were facing declining foot traffic, pricing pressures due to excess inventories, and rising competition from eCommerce players, off-price retailers such as Ross Stores continued to show strong top-line growth and took market share at the expense of traditional retailers.
Now is a good time to look at dividend stocks to buy and hold. While there’s no doubt that the market averages were on a roll going in 2018, that incredible momentum slowed a bit when January changed to February. The tax cuts in late December added a lot of fuel to stocks’ fire, but a market correction was lurking around the corner.
PSA.PRA PSA.PRB STX AES.PRC PSA.A PSAXZ PSA.PRG AES PSA.PRE PSA.PRF PSA.PRC PSA.PRD DUKH PSA.PRY PSA.PRZ CG M DUK PSA.PRW PSA.PRX PSA.PRU PSA.PRV PSA PSA.PRS PSA.PRT CTT
Investors in Macy's, Inc. (M - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 17, 2018 $22.00 Call had some of the highest implied volatility of all equity options today.
Investors focused on the Retail-Wholesale space have likely heard of Macy's (M - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of M and the rest of the Retail-Wholesale group's stocks.
Headlines about the death of the American shopping mall have become so common that the phrase "retail apocalypse" has its own Wikipedia page. But this is a death wrongly foretold - and that creates investment opportunities.
SHLD TJX JCP M SHLDW
Its that time of year again, with the fourth Prime Day scheduled to kick off at 3 pm E.T on Monday, July 16th. Wall Street (i.e. the sell side) has been fairly quiet about Prime Day this year vs. last year. Perhaps their attention are fixated on trade tensions between China and the US, and on Amazon's recent foray into healthcare. However, they should be thinking more about Prime Day 2018, which I think is set to exceed all expectations.
WFM TGT KSS M BBBY WMT
I’ve been a huge bull on beaten-up retail stocks over the past year. The narrative has sharply reversed course from Amazon (NASDAQ:AMZN) killing all of retail to traditional retailers fighting back by remodeling their stores, building out omni-channel sales capability, incorporating more loyalty perks, and discounting prices to reasonable-yet-attractive levels.
JWN AMZN KSS M ANF URBN
As of this writing, William White did not hold a position in any of the aforementioned securities.
Is Walmart Inc (NYSE:WMT) the top retail stock to buy? Given that WMT stock is down 14.5% this year, the answer seems like a resounding “no.” However, some are wondering if now is the time to load up on the company.
HD TGT KR AMZN T CVX M CLX WMT
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to M / Macy's, Inc. on message board site Silicon Investor.
as of ET